Extracorporeal removal of drugs refers to the use of external mechanical systems to eliminate drugs or toxins from the bloodstream. This technique is primarily used in cases of severe drug overdose, poisoning, or when renal failure limits natural drug elimination. Various extracorporeal therapies—such as hemodialysis, hemoperfusion, and continuous renal replacement therapy (CRRT)—help remove drugs efficiently by replacing or supporting impaired kidney function.
When Is Extracorporeal Drug Removal Needed?
Extracorporeal removal is recommended in the following situations:
- Life-threatening drug overdose
- Drugs with narrow therapeutic index causing toxicity
- Substances with prolonged half-life
- Renal failure preventing normal drug clearance
- Ingestion of dialyzable toxins
- Failure of supportive care alone
Extracorporeal removal acts rapidly, making it a lifesaving measure in acute toxicological emergencies.
Factors Determining Drug Removal by Extracorporeal Methods
The ability of a drug to be removed depends on several pharmacokinetic characteristics:
1. Molecular Weight
Low molecular weight (< 500 Da) drugs are easily removed by hemodialysis.
2. Protein Binding
Highly protein-bound drugs (e.g., warfarin, diazepam) are poorly dialyzable.
3. Volume of Distribution (Vd)
- Low Vd (< 1 L/kg) → good removal (drug confined to bloodstream)
- High Vd → poor removal (drug stored in tissues)
4. Water Solubility
Hydrophilic drugs are more effectively removed.
5. Clearance Mechanism
Drugs mainly eliminated by kidneys respond best to extracorporeal techniques.
Main Extracorporeal Drug Removal Techniques
1. Hemodialysis
Hemodialysis removes drugs by diffusion across a semi-permeable membrane driven by concentration gradients.
Characteristics of Drugs Well Removed by Hemodialysis
- Low molecular weight
- Low protein binding
- Low volume of distribution
- Water soluble
Examples of Dialyzable Drugs
- Metformin
- Lithium
- Aminoglycosides
- Phenobarbital
- Salicylates (partially)
Hemodialysis is also helpful in removing toxic metabolites as seen in methanol and ethylene glycol poisoning.
2. Hemoperfusion
Hemoperfusion involves passing blood over adsorbent materials such as activated charcoal or resin. This method is particularly effective for removing lipid-soluble and protein-bound drugs that dialysis cannot remove efficiently.
Drugs Effectively Removed by Hemoperfusion
- Theophylline
- Carbamazepine
- Barbiturates
- Paraquat
Advantages
- Removes both free and some protein-bound drugs
- Rapid toxin clearance
Disadvantages
- Thrombocytopenia
- Hypocalcemia
- Not effective for high Vd drugs
3. Continuous Renal Replacement Therapy (CRRT)
CRRT is used mainly in critically ill patients who cannot tolerate rapid fluid shifts of intermittent hemodialysis. Drug removal occurs by diffusion, convection, or a combination of both.
Types of CRRT
- CVVH – Continuous Venovenous Hemofiltration
- CVVHD – Continuous Venovenous Hemodialysis
- CVVHDF – Combined Hemofiltration & Hemodialysis
CRRT removes drugs more slowly but continuously, making it ideal for hemodynamically unstable patients.
4. Plasma Exchange (Plasmapheresis)
Plasma exchange removes drugs contained in plasma by replacing it with donor plasma or albumin solutions.
Useful For
- Highly protein-bound drugs
- Large molecular drugs
- Antibodies and immune complexes
However, it is not typically first-line for most drug overdoses.
5. Peritoneal Dialysis
Peritoneal dialysis uses the peritoneal membrane as a natural dialysis filter. Drug removal is slow and inefficient compared to hemodialysis.
Limited Indications
- Overdose with dialyzable drugs when hemodialysis is unavailable
- Pediatric patients or those intolerant to hemodialysis
Clinical Indications for Extracorporeal Removal of Drugs
These procedures are recommended in cases of:
- Severe poisoning unresponsive to supportive therapy
- Drugs with long half-life causing persistent toxicity
- Severe metabolic acidosis
- Renal failure preventing normal drug elimination
- Drugs with significant risk of morbidity or mortality
The decision is guided by clinical condition, drug characteristics, and availability of extracorporeal options.
Drugs Not Suitable for Extracorporeal Removal
These drugs have properties that limit their extracorporeal clearance:
- High protein binding (e.g., warfarin)
- High lipid solubility
- Large volume of distribution (e.g., digoxin, benzodiazepines)
- Strong tissue binding (e.g., tricyclic antidepressants)
Complications of Extracorporeal Removal
- Hypotension
- Electrolyte disturbances (hypokalemia, hypocalcemia)
- Infections
- Bleeding from anticoagulation
- Thrombocytopenia (especially with hemoperfusion)
Monitoring during therapy is essential to detect and manage these risks.
Detailed Notes:
For PDF style full-color notes, open the complete study material below: